drugset / Trial / NCT05317442
Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound
Phase 4
Terminated
10 enrolled
Taipei Medical University WanFang Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital · collabOneness Biotech Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound
Timeline
- Start
- 2022-04-06
- Primary completion
- 2024-04-19
- Completion
- 2024-04-19
Outcome
Outcome not reported
Stopped: “Study halted prematurely and will not resume.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fespixon Cream | Unknown | 1 ml | Topical |
Indications
No indication recorded.